Beta | 95% CI* | p Value* | ||
(A) NIHSS shift | ||||
Thrombectomy | −3.74 | −6.02 | −1.50 | 0.016 |
Gender (M) | −2.55 | −5.38 | −.135 | 0.147 |
CTA collateral | −1.26 | −3.09 | 0.06 | 0.206 |
Age | 0.03 | −.021 | 0.08 | 0.284 |
Intravenous tPA | −0.12 | −3.56 | 3.57 | 0.951 |
MCA M2† | 0.08 | −2.33 | 2.76 | 0.960 |
MCA M1† | 0.01 | −2.66 | 2.12 | 0.993 |
Basilar† | 0.36 | −3.65 | 6.79 | 0.899 |
(B) Good outcome at discharge | ||||
Thrombectomy | −21.85 | −41.35 | −20.77 | 0.002 |
MCA M1 | 0.89 | −0.51 | 2.63 | 0.175 |
Gender (M) | 0.68 | −0.29 | 2.10 | 0.201 |
Intravenous tPA | 0.64 | −1.63 | 20.57 | 0.425 |
Baseline NIHSS | 0.10 | −0.17 | 0.43 | 0.463 |
Intracranial ICA | 0.23 | −1.21 | 1.70 | 0.716 |
Basilar | −0.32 | −4.72 | 2.35 | 0.775 |
Age | 0.01 | −.034 | 0.05 | 0.791 |
CTA collateral | 0.01 | −0.88 | 0.81 | 0.978 |
(C) Good outcome at long-term follow-up | ||||
Thrombectomy | −21.11 | −39.07 | −19.70 | 0.003 |
Intravenous tPA | 0.90 | −1.20 | 19.89 | 0.216 |
Intracranial ICA | −0.84 | −21.09 | 0.67 | 0.264 |
CTA collateral | −0.47 | −2.32 | 0.25 | 0.280 |
Basilar | −1.36 | −23.81 | 1.08 | 0.389 |
MCA M1 | −0.56 | −3.32 | 0.89 | 0.469 |
Baseline NIHSS | 0.10 | −0.24 | 0.48 | 0.509 |
Age | −0.00 | −0.06 | 0.05 | 0.796 |
Gender (M) | 0.13 | −1.39 | 2.15 | 0.857 |
*Bootstrap results based on 2000 samples.
†compared with intracranial ICA occlusions.
CTA, CT angiography; ICA, intracranial carotid artery; MCA, middle cerebral artery; NIHSS, National Institute of Health Stroke Scale; tPA, tissue plasminogen activator.